Comerica Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Comerica Bank’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,022	Closed	-$127K	–	2242
2014 Q1	$127K	Buy	2,022 +30	+2%	+$1.99K	﹤0.01%	2204
2013 Q4	$117K	Sell	1,992 -34	-2%	-$1.78K	﹤0.01%	2188
2013 Q3	$107K	Hold	2,026	–	–	﹤0.01%	2502
2013 Q2	$156K	Buy	+2,026	New	+$165K	﹤0.01%	2152

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Comerica Bank's ARNA Position: Q2 2014 in Review

Comerica Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 2,022 shares — an estimated $127K sold.

Comerica Bank first reported a position in ARNA in Q2 2013 and held it in 4 quarters. The position peaked at $156K in Q2 2013. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

Comerica Bank reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
Comerica Bank sold 2,022 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $127K.
Comerica Bank first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Comerica Bank's Arena Pharmaceuticals Inc position peaked at $156K in Q2 2013.
129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.